ABANZA
Development and research of innovative medical instruments, devices and biotechnology in the field of sports medicine.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $5.0m | Seed |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 644 % | (49 %) | 360 % | (55 %) | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (3437 %) | (613 %) | (1595 %) | (193 %) | (1205 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (2123 %) | (374 %) | (933 %) | 5 % | (612 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
ABANZA is a pioneering company in the field of Orthopedics and Arthroscopic Soft Tissue Repair. The company is dedicated to developing innovative medical solutions that enhance the quality of life for patients. ABANZA's primary focus is on creating new treatment concepts and improving existing procedures in the realm of sports medicine and soft tissue surgery.
The company serves a diverse clientele, including surgeons, hospitals, and patients who require advanced orthopedic and soft tissue repair treatments. Operating in the healthcare market, ABANZA is committed to addressing unresolved medical needs through continuous research and development. This involves close collaboration with medical professionals and key opinion leaders, ensuring that their products meet the highest standards of efficacy and safety.
ABANZA's business model revolves around innovation and quality management. The company invests heavily in research to explore disruptive ideas, build proof of concepts, and generate clinical evidence. This research-driven approach allows ABANZA to stay at the forefront of medical advancements and offer cutting-edge solutions to its clients.
Revenue generation for ABANZA comes from the sale of its innovative medical products and solutions to hospitals and medical professionals. By participating in major medical trade fairs and congresses, such as the MEDICA Trade Fair in Germany and the SECOT Congress in Seville, ABANZA showcases its latest innovations and expands its market reach.
In summary, ABANZA is a forward-thinking company dedicated to improving orthopedic and soft tissue repair procedures through innovation and collaboration with the medical community. Their commitment to quality and continuous improvement positions them as a key player in the healthcare market.
Keywords: Orthopedics, Soft Tissue Repair, Innovation, Research, Quality Management, Sports Medicine, Medical Solutions, Surgeons, Hospitals, Patients.